Calithera Biosciences, Inc. (CALA)
Chart Events
Performance Outlook
| Previous Close | 0.7650 |
| Open | 0.7649 |
| Bid | 0.8150 x 800 |
| Ask | 0.8282 x 1800 |
| Day's Range | 0.7558 - 0.8300 |
| 52 Week Range | 0.7558 - 6.1850 |
| Volume | |
| Avg. Volume | 1,685,985 |
| Market Cap | 60.356M |
| Beta (5Y Monthly) | 1.68 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.2170 |
| Earnings Date | May 06, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.00 |
- Zacks
Do Options Traders Know Something About Calithera Biosciences (CALA) Stock We Don't?
Investors need to pay close attention to Calithera Biosciences (CALA) stock based on the movements in the options market lately.
- InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning, investor! We’re getting right into the thick of it today with a look at the biggest pre-market stock movers for Thursday! Source: ventdusud / Shutterstock.com Earnings reports, IPOs, acquisition news, and more have stocks moving during this morning’s pre-market trading. Let’s dive into those pre-market stock movers below!InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-Market Stock Movers: 10 Top Gainers Sono Group (NASDAQ:SEV) stock is soaring more than 27% after
- GlobeNewswire
Calithera to Present at the 2021 Jefferies London Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision oncology biopharmaceutical company, today announced that Susan Molineaux, Ph.D., the company’s founder, president and chief executive officer, will present at the 2021 Jefferies London Healthcare Conference. The presentation will be available for on-demand viewing starting Thursday, November 18 at 3:00 a.m. Eastern Time, and can be accessed through the Investors
